MS risk and relapses: unlocking new clues from our genes
14 July 2021
Genes affect the risk of developing MS, but what about MS relapses? Two new studies uncover clues to MS biology hidden in our genetic code.
Genes affect the risk of developing MS, but what about MS relapses? Two new studies uncover clues to MS biology hidden in our genetic code.
MS is traditionally split into subtypes: relapsing-remitting, secondary-progressive, primary-progressive and progressive-relapsing. Researchers are now exploring three different subtypes based on machine learning.
New research explores how crises such as the Australian bushfires and COVID-19 pandemic have affected the health behaviours of people with MS in Australia.
Rohan Greenland provides an update on the latest research and advocacy efforts from MS Australia and it’s recently amalgamated research arm, MS Research Australia.
Minister for the NDIS, Linda Reynolds, has confirmed that the NDIS will not proceed with introducing independent assessments.
MS Australia is inviting the MS community to take part in an online survey about MS research and advocacy priorities. Your opinion will help shape the future of MS Australia’s research and advocacy priorities and champion the interests of Australia’s MS community.
The FDA’s Letter of Support will stimulate studies that advance development and validation of Nfl as a biomarker to speed clinical trials in progressive MS.
Each year, World MS Day brings together the global MS community to raise awareness, advocate for better services
Our CEO, Rohan Greenland, gives a heartfelt thank you to the entire MS community and the broader Australian public for your superb participation in, and support of, The May 50K.